against in Biological Technology

BioNeutral's Ygiene(TM) Hospital Grade Achieves a 100% Total Kill (Pass) Against the Life Threatening Clostridium Difficile (C.diff) Spores in Independent EPA Required Protocol Testing.

NEWARK, N.J., July 21 /PRNewswire-FirstCall/ -- BioNeutral Group, Inc. ("BioNeutral") (OTC Bulletin Board: BONU), a specialty chemical technology based Life Science Company announced today that at ATS Labs using the required EPA protocol testing, BioNeutral's Ygiene(TM) Hospital Grade Antimic...

BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial Demonstrates a 99.9997% Kill Rate Against Clostridium Difficile Spores (C.diff) in Independent Lab Pre-testing Phase

NEWARK, N.J., July 9 /PRNewswire-FirstCall/ -- BioNeutral Group, Inc. ("BioNeutral") (OTC Bulletin Board: BONU), a chemical technology-based Life Science company announced today that at ATS Labs, using a Quantitative Disk Carrier test starting with 5.5 million Clostridium Difficile (C.diff) spores...

Sugarcane as a Key Element Against Global Warming to be Highlighted at Green Week in Brussels

SAO PAULO, June 23 /PRNewswire/ -- What does sugarcane have to do with Global Warming? Everything, when you consider Brazil's highly successful, 30-year experience with sugarcane as a feedstock for ethanol. In place since the mid-70s, the largest program in the world to replace a fossil fuel w...

BD and FIND Achieve Milestone in Global Battle Against MDR-TB

Price reductions for liquid culture tests will accelerate access to improved TB diagnostics SEATTLE, June 17 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company; NYSE: BDX ), a leading global medical technology company, and FIND (Foundation for Innovative New Diagnostics), a Swiss f...

New Phase 3 Data Continue to Indicate that Wyeth's Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease

COLLEGEVILLE, Pa., June 11 /PRNewswire-FirstCall/ -- New data from Phase 3 European clinical trials reinforce that Wyeth's (NYSE: WYE ) investigational pneumococcal vaccine, Prevenar 13* (Pneumococcal Polysaccharide Conjugate Vaccine, 13-valent [Adsorbed]), has the potential to provide cov...

Celator(R) Pharmaceuticals Presents Data on the Activity of CPX-351 Against Leukemia at the European Hematology Association Congress

PRINCETON, N.J., June 8 /PRNewswire/ -- Celator Pharmaceuticals today announced that new clinical and preclinical data demonstrating the extended therapeutic bioavailability and tumor cell selectivity of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in leukemia were presented at the 14th Co...

Haemonetics Receives Favorable Ruling in Patent Lawsuit against Competitive Technology

BRAINTREE, Mass., June 4 /PRNewswire-FirstCall/ -- Haemonetics Corporation (NYSE: HAE ) announced today that the U.S. District Court for the District of Massachusetts has made a ruling in the Company's lawsuit against Fenwal, Inc. In January 2009, a jury issued a verdict in favor of Haemone...

Novavax and the NIH Agree to Evaluate a Virus-like Particle (VLP) Vaccine Candidate Against the Novel Influenza A (H1N1) Virus

Company completes initial steps towards producing Influenza A (H1N1) VLP vaccine for animal and human testing ROCKVILLE, Md., June 4 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) and the Division of Microbiology and Infectious Diseases (DMID) of the National Institute of Allergy a...

Structure of enzyme against chemical warfare agents determined

This release is available in German . The enzyme DFPase from the squid Loligo vulgaris , is able to rapidly and efficiently detoxify chemical warfare agents such as Sarin, which was used in the Tokyo subway attacks in 1995. A detailed understanding of the mechanism by which enzymes ca...

SANYO Donates Air Purification Systems Effective Against Flu Viruses to New York Airports and Schools

Some Recipients have recently faced H1N1 Flu Outbreaks JAMAICA, N.Y., May 26 /PRNewswire/ -- SANYO Biomedical and Environmental Solutions (SANYO), a division of SANYO North America, announces the donation of professional-use air purification systems to provide an added level of safe, healthy ...

CEL-SCI Developing Immune-Based Treatment Against Swine and Other H1N1 Flu Viruses Using Proprietary L.E.A.P.S. Technology

VIENNA, Va. May 26 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE AMEX: CVM ) announced today that it is developing an immune-based treatment for the "swine flu and related H1N1" flu viruses, utilizing its proprietary L.E.A.P.S.(TM) (Ligand Epitope Antigen Presentation System) vaccine tec...

Onyx Pharmaceuticals Files Complaint Against Bayer Corporation

Asserts Rights to Phase 2 Anti-Cancer Compound Discovered During Joint Research EMERYVILLE, Calif., May 17 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it has filed a complaint in the United States District Court for the Northern District of Cal...

The Court Supports Bavarian Nordic's Decision to Start Patent Infringement Case Against Oxford BioMedica

KVISTGARD, Denmark, May 9 /PRNewswire-FirstCall/ -- Oxford Biomedica's second attempt to dismiss Bavarian Nordic's patent infringement suit in the United States has failed. Instead of denying infringement, Oxford Biomedica made yet another attempt to dismiss the suit arguing that it was premat...

Spectros Corporation Protects Its Cool White LED Spectroscopy Technology Against Alleged Infringement by Thermo Fisher Scientific

PORTOLA VALLEY, Calif., May 6 /PRNewswire/ -- Spectros Corporation (Portola Valley, CA) filed in Federal District Court today against Thermo Fisher Scientific (NYSE: TMO ), alleging infringement of Spectros' spectroscopy patent family by TMO's Nanodrop 3300 product. Spectros invented and commerc...

Germgard's Ultra-Fast Hand Hygiene Solution Protects Against Deadly MRSA, C difficile, and Influenza Virus

DOVER, N.J., April 29 /PRNewswire/ -- In an effort to provide technology to reduce healthcare-associated infections, Germgard Lighting LLC, a New Jersey-based early-phase medical device company, has demonstrated its patented ultra-fast (~1 second) hand hygiene solution. The solution is designed to...

Structure of enzyme against chemical warfare agents determined

This release is available in German . The enzyme DFPase from the squid Loligo vulgaris , is able to rapidly and efficiently detoxify chemical warfare agents such as Sarin, which was used in the Tokyo subway attacks in 1995. A detailed understanding of the mechanism by which enzymes ca...

NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains

H1N1 Virus-like Particle (VLP) Vaccine Candidate Based on the 1918 Spanish Influenza Strain Protected Mice and Ferrets Against the Spanish Flu and Highly Pathogenic H5N1 Bird Flu ROCKVILLE, Md., April 14 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) today reported preclini...

Pepscan Achieves a Breakthrough With CLIPS Immunogen Technology: Synthetic Peptide Antigen is Able to Induce Fully Functional Antibodies Against a Formerly Intractable GPCR Target CXCR7

LELYSTAD, The Netherlands, April 6 /PRNewswire/ -- Today, Pepscan reports that it has achieved a major scientific breakthrough through the use of its CLIPS-based synthetic peptide immunogen technology. By constructing synthetic 3D mimics of the ligand binding-site on CXCR7 it has induced funct...

Shire Files Lawsuit Against Natco Pharma for Infringement of FOSRENOL(R) (lanthanum carbonate) Patents

PHILADELPHIA, April 2 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY ) announces that it has filed a lawsuit in the U.S. District Court for the Southern District of New York against Natco Pharma Limited ("Natco") for infringement of two of Shire's patents: U.S. Patent No. 5,968...

AstraZeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer

2009 Artery Explorer Tour Kicks Off This Month, Urging People Across the Country to Take Action Against Atherosclerosis WILMINGTON, Del., March 24 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN ) today announced the launch of the 2009 US AGAINST ATHERO tour featuring the Artery Explorer ...

Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent

PHILADELPHIA, Pennsylvania and DUBLIN, Ireland, March 20 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY ) announces that it has filed a lawsuit in the U.S. District Court of the Southern District of New York against Mylan Inc., Mylan Pharmaceuticals Inc. and Matrix Laboratories...

Structure of enzyme against chemical warfare agents determined

This release is available in German . The enzyme DFPase from the squid Loligo vulgaris , is able to rapidly and efficiently detoxify chemical warfare agents such as Sarin, which was used in the Tokyo subway attacks in 1995. A detailed understanding of the mechanism by which enzymes ca...

Shire Files Lawsuit Against Barr Laboratories for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patents

PHILADELPHIA, Pennsylvania and DUBLIN, Ireland, March 16 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY ) announces that it has filed a lawsuit in the U.S. District Court of the Southern District of New York against Barr Laboratories, Inc. ("Barr") for infringement of three of ...

Pro Hockey Player Fernando Pisani Looks to Shoot and Score Against Ulcerative Colitis

As Part of "In the Zone for UC" Campaign, Centocor Ortho Biotech Inc. Will Donate $5,000 to the Crohn's & Colitis Foundation of America for Each Point Pisani Scores During 2008-2009 Season HORSHAM, Pa., March 2 /PRNewswire/ -- Centocor Ortho Biotech Inc. announced today a partnership wit...

NOVAVAX Announces Preclinical Study Results for a Respiratory Syncytial Virus ('RSV') Vaccine Candidate Directed Against the Fusion (F) Protein

Preclinical Study Shows the Investigational RSV-F Virus-like Particle Vaccine Induced Neutralizing Antibodies and Protected Mice upon Challenge ROCKVILLE, Md., Feb. 27 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) announced results from a preclinical study of a Respiratory Syncyti...

Investor Group Files Complaint With Irish Office of the Director of Corporate Enforcement Against Named Directors of Trinity Biotech

KANSAS CITY, Mo., Feb. 24 /PRNewswire/ -- An investor group in Trinity Biotech plc (Nasdaq: TRIB ), an Irish based developer and manufacturer of diagnostic products, has petitioned the Office of the Director of Corporate Enforcement to facilitate compliance with key company law provisions de...

Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets

LONDON, February 24 /PRNewswire/ -- - Syndicate Comprises Leading Sector Investors Clarus Ventures, MVM Life Science Partners and Novartis Option Fund Heptares Therapeutics Ltd, the drug discovery company focused on drugs targeting G-protein-coupled receptors (GPCRs), announces t...

Mosquito genes linked to insecticide resistance may be new target in fight against malaria

Malaria remains one of the most serious diseases worldwide, claiming the lives of more than one million people per year in tropical and sub-tropical regions, the majority of whom are children under five years of age. Efforts to eliminate this mosquito-borne illness rely heavily on prevention meas...

Vaccine Against the Chikungunya Virus in Development by a Public-Private Partnership

LEIDEN, The Netherlands, February 4 /PRNewswire/ -- Top Institute Pharma (TI Pharma) has formed a consortium with Wageningen University, Erasmus University Medical Centre and Nobilon, a subsidiary of Schering-Plough, to develop a 'proof of concept' vaccine against the Chikungunya virus. This...

IDRI Collaborates with the Brazilian Butantan Institute To Develop Novel Vaccines Against Leishmaniasis

SEATTLE, Jan. 22 /PRNewswire/ -- IDRI (Infectious Disease Research Institute) announced it has granted the Instituto Butantan, a Brazilian biomedical research institution, an exclusive license in Latin America and a non-exclusive license in the rest of the world to use two of IDRI's lead vacci...

Court of Appeals Overturns 2005 Patent Verdict Against Cordis

WARREN, N.J., Jan. 15 /PRNewswire/ -- The Court of Appeals for the Federal Circuit in Washington, D.C. today found Boston Scientific Corporation's Ding patent invalid, and reversed a 2005 jury finding that Cordis Corporation's CYPHER(R) Sirolimus-eluting Coronary Stent infringed that patent. ...

Bavarian Nordic's Case Against Oxford BioMedica

KVISTGARD, Denmark, January 12 /PRNewswire-FirstCall/ -- Bavarian Nordic owns several United States patents relating to an attenuated strain of the company's core technology, MVA-BN(R), which is the basis for its smallpox vaccine, IMVAMUNE(R). MVA-BN(R) also holds promise as a vector for deliv...

Gene against bacterial attack unravelled

Humans have an innate defence system against deadly bacteria. However, how the step from gene to anti-bacterial effect occurs in the body is not yet known. To date, B. Pseudomallei, a bacterium suitable for bioweapons, had managed to elude medics. It can remain hidden in the human body for many ...

Shareholder Class Action Filed Against Elan Corporation, plc by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP

RADNOR, Pa., Dec. 11 /PRNewswire/ -- The following statement was issued today by the law firm of Barroway Topaz Kessler Meltzer & Check, LLP: Notice is hereby given that a class action lawsuit was filed in the United States District Court for the Southern District of New York on beha...

Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals

FRAZER, Pa. and PHILADELPHIA, Nov. 26 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH ) and Eurand, Inc. (Nasdaq: EURX ) today announced that they have filed a lawsuit in U.S. District Court in Delaware against Mylan Pharmaceuticals, Inc. and its subsidiary, Mylan, Inc., and Barr Pharma...

UCF professor develops vaccine to protect against black plague bioterror attack

A University of Central Florida researcher may have found a defense against the Black Plague, a disease that wiped out a third of Europe's population in the Middle Ages and which government agencies perceive as a terrorist threat today. UCF Professor Henry Daniell and his team have developed a...

Occlutech Obtains Favourable Court Ruling in Patent Litigation in The Hague Against AGA Medical

JENA, Germany, October 30 /PRNewswire/ -- Occlutech GmbH, the leading European manufacturer of cardiac occlusion devices, today announced that it has won its litigation case in The Hague, Holland, against AGA Medical Inc. regarding non-infringement of the Dutch version of the European patent; ...

Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic

Preclinical Animal Data Demonstrates Selective Survival Advantage of ZFN-Treated Immune Cells after HIV Infection and Reduced Viral Loads WASHINGTON and RICHMOND, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today the presentation of data de...

New Company to Develop Nutritional Interventions Against Chronic Inflammatory and Infectious Diseases

BLACKSBURG, Va., Oct. 17 /PRNewswire-USNewswire/ -- A new company is being created as a spin-off from Virginia Tech research to develop nutritional interventions against chronic inflammatory and infectious diseases. BioTherapeutics Inc. will promote health and well-being through the discovery ...

BIO Ventures for Global Health Receives $7 Million Grant from Gates Foundation to Engage Biotechnology in the Fight Against Neglected Diseases of the Developing World

-Funds to support creation of market incentives and facilitate new R&D collaborations- WASHINGTON, Oct. 14 /PRNewswire-USNewswire/ -- BIO Ventures for Global Health (BVGH) today announced that the Bill & Melinda Gates Foundation has expanded its support of the organization, so it can further...